Quince Therapeutics, Inc. (QNCX): Going concern doubt
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
The Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.
Why it matters
A going-concern disclosure reflects substantial doubt about the company's ability to continue operating.